Straumann Holding AGXSWX:STMN -0.42%98 PB Ratio is 7.85 as of Jun. 28, 2026, which is 28% below its 10-year median of 10.84. GuruFocus rates XSWX:STMN with a GF Score™ of 98/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 87.8% on this metric.
Straumann Holding AG stock PB Ratio (=7.85) is close to 1-year high of 8.55.
The historical rank and industry rank for Straumann Holding AG's PB Ratio or its related term are showing as below:
XSWX:STMN'
s PB Ratio Range Over the Past 10 Years
Min: 5.59 Med: 10.84 Max: 27.04
Current: 7.85
During the past 13 years, Straumann Holding AG's highest PB Ratio was 27.04. The lowest was 5.59. And the median was 10.84.
XSWX:STMN's PB Ratio is ranked worse than 87.8% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 1.99
vs XSWX:STMN: 7.85
During the past 12 months, Straumann Holding AG's average Book Value Per Share Growth Rate was 5.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Straumann Holding AG was 30.10% per year. The lowest was -2.90% per year. And the median was 7.90% per year.
Back to Basics: PB Ratio
Straumann Holding AG (XSWX:STMN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Straumann Holding AG PB Ratio Related Terms
Straumann Holding AG PB Ratio Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Straumann Holding AG (XSWX:STMN) has a PB Ratio of 7.85 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Straumann Holding AG and its competitors. This is 28% below median its historical median of 10.84. Over the past decade, Straumann Holding AG's PB Ratio has ranged from 5.59 to 27.04. According to the industry distribution chart, Straumann Holding AG ranks #691 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 87.8%.
Is Straumann Holding AG's PB Ratio too high?
Straumann Holding AG's current PB Ratio of 7.85 is 28% below median its 10-year median of 10.84. Over the past 10 years, this metric has ranged from a low of 5.59 to a high of 27.04. The Medical Devices & Instruments industry median PB Ratio is 1.99. Straumann Holding AG's value of 7.85 is 294.5% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #691 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Straumann Holding AG has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #691 out of 787 companies for PB Ratio. This places Straumann Holding AG in the lower half of its industry. The industry median PB Ratio is 1.99. Straumann Holding AG's value of 7.85 is 294.5% above this benchmark. Historically, Straumann Holding AG's own PB Ratio has ranged from 5.59 to 27.04 over the past decade. While the company's 10-year median is 10.84 vs. the industry median of 1.99, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 1.99, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current PB Ratio of 7.85 is 294.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current PB Ratio is 7.85, which is 28% below median its own 10-year median of 10.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.35 — trading 22.3% below its estimated fair value. The current PB Ratio is 7.85, which is 28% below median its 10-year median of 10.84 and 294.5% above the Medical Devices & Instruments industry median of 1.99. Straumann Holding AG's overall GF Score™ is 98/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current PB Ratio is 7.85 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.35 is trading 22.3% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
PB Ratio: 7.85 (28% below median its 10-year median of 10.84)
GF Value™: CHF136.92 vs. price of CHF106.35 (22.3% below fair value)
Industry Position: 294.5% above the Medical Devices & Instruments median (#691 of 787)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
98GF Score
Get the complete analysis for XSWX:STMN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
